The solution for the titration of oral solid drugs!
Personalized treatment matters — especially for vulnerable patients like children and the elderly, who need doses tailored to their bodyweight or medical condition. Although around 70% of drugs are delivered in solid oral forms, there is still no easy and precise solution for dose personalization!
- Insulin pens transformed diabetes.
- Inhalers transformed asthma.
- Now we want to transform oral solids.
Together, we can set the new global standard for oral drug delivery.
Enabling bodyweight-based dosing (e.g. pediatric)
Reducing side effects and dose errors
Allowing drug titration (e.g. loading & maintenance doses)
Reduction of Cost of Goods Sold (COGS), as one product covers all dosages strengths.
Patented
WHY POWDOSE
The oral solid drug primary packaging with titration function
Patient-centric design focused on usability. The user will only perform 2 steps to get the right and precise needed amount of drug.
Therapeutical Area agnostic and seamless to incorporate into the drug product. Ready-to-use and prefilled with the oral medicine.
Low carbon footprint. Made of a limited number of environmentally friendly sustainable polymers.
Extended stability. The encapsulated container design ensures high moisture and humidity protection (desiccant can be integrated as part of the device).
Partnership
Reimagine personalized dosing with POWDOSE
POWDOSE is an innovative dosing and primary packaging solution offered to pharmaceutical partners seeking to combine precise dosing of oral solid drugs with simplicity.
The drug remains in dry solid form until administration, improving stability and ensuring reliable access to the medicine.
Partner with us to bring POWDOSE to your formulation. Our co-development programs help tailor dose ranges and optimize the delivery experience for your specific therapy.
The POWDOSE allows personalization of doses of solid drug.
The POWDOSE adds value to the drug product ("Value-Added Medicine") and propose a differentiation against the competition.
The POWDOSE is a platform applicable to multiparticulates, minitablets or granulate-based medicine where the dose needs to be tailored to the patient’s bodyweight and condition.
Leadership
Management
Strong Independent US/EU Board
Thierry Jomini
CEO - Founder (based in CH - Lausanne)
15 years’ experience in leading drug delivery devices and combination products development for various application such as diabetes, Parkinson disease or hormone therapies.
Stephen M. Perry
CEO - Founder (based in RTP/USA)
He is the CEO and Founder of Kymanox where he leads a team of 300 professionals worldwide and has been formally recognized as a top CEO in the Research Triangle Park (RTP) region. He has successfully attracted growth capital from investors and has further grown the unique Kymanox platform with the acquisition of four companies. He has also helped several CEOs raise Series A venture capital.
Greg Cash
Chairman - Founder (Minneapolis)
Transformational and innovative life sciences CEO with a proven track record of growing and turning around businesses with significant value creation. Domain expertise in medical devices, mobile and digital health and pet health. Has been Chief Executive of several medical device companies, both public and privately held, as well as run units of larger entities.
Dr. Dirk Kreder
Entrepreneur, Investor and Senior Advisor (Munich)
25 years of experience in small and mid-size biotech and global pharma companies in the US and Europe with focus on Medical Device and drug development and registration. Dirk is a recognized leader in North America, Europe, and Asia to support customers in Pharma and Biotech, especially Biosimilar developers, in their medical device needs.
Paul Dunne
Entrepreneur and Business Development Manager (Dublin/Austria)
An experienced Commercial manager in the pharmaceutical industry with over 15 years working in the CDMO and R&D field facilitating interactions with Large Pharma, Biotech and Generic manufactures. Paul was co-founder of Advande Labs. A fully GMP FDA accredited analytical laboratory servicing the international pharma, Biotech, Nutraceutical and Veterinary industry.
Corporate & Institutional Support
AbbatiaLabs is a startup specialized in innovation at the edge of medical technologies and pharmaceutical development. We want to set a new standard for the personalization of solid drugs!
We are offering a "positive social impact" investment, dedicated to improving the quality of life for children through better, more suitable Child-Appropriate Formulations (CAF), in alignment with priorities set by the WHO and other health authorities worldwide.
Contact us